Metastatic Non-Small Cell Lung Cancer (MSK, Nature Medicine 2022)

Summary

Metastatic Non-Small Cell Lung Cancer (MSK, Nature Medicine 2022) is a study catalogued by cBioPortal DataHub under the cancer-type code nsclc. EvidenceHelix groups it with lung and pleura studies.

Study description

Targeted sequencing of ctDNA samples drawn from patients with metastatic NSCLC using the Resolution ctDx Lung platform. For more information contact jeej@mskcc.org or lib1@mskcc.org

Text as published in the source's study metadata.

Citation & PubMed

Jee et al. Nature Medicine 2022

Linked PubMed records: PMID 36357680

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

nsclc_ctdx_msk_2022

Short name

NSCLC (MSK, 2022)

Source cancer-type code

nsclc

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Jee et al. Nature Medicine 2022

• PubMed record 36357680 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)

  Whole-exome sequencing of 75 tumor/normal NSCLC pairs treated with PD-1 plus CTLA-4 blockade..

  Lung and pleuraMSK studiesSource code nsclcPubMed 1

• Non-Small Cell Lung Cancer (MSK, J Clin Oncol 2018)

  IMPACT sequencing of 240 NSCLC tumor/normal pairs treated at MSKCC with anti-PD-(L)1 based therapy.

  Lung and pleuraMSK studiesSource code nsclcPubMed 1

• Non-Small Cell Lung Cancer (MSK, Science 2015)

  Whole exome sequencing of tumor-normal tissue pairs from 16 non-small cell lung cancer samples.

  Lung and pleuraMSK studiesSource code nsclcPubMed 1

• Non-Small Cell Lung Cancer Brain Metastasis (MSK, Nat Commun 2023)

  Targeted sequencing of 322 NSCLC brain metastasis and their matched normals via MSK-IMPACT.

  Lung and pleuraMSK studiesSource code nsclcPubMed 1

• Non-Small Cell Lung Cancer (TRACERx, NEJM & Nature 2017)

  Whole-exome sequencing of 327 primary tumors with matched germline samples, and phylogenetic ctDNA sequencing of 96 pre- and 24 postoperative samples from 100 NSCLC TRACERx patients.

  Lung and pleuraOther published and consortium studiesSource code nsclcPubMed 2

• Non-Small Cell Lung Cancer (University of Turin, Lung Cancer 2017)

  Targeted next-generation sequencing of 41 NSCLC samples.

  Lung and pleuraOther published and consortium studiesSource code nsclcPubMed 1

• Pan-Lung Cancer (TCGA, Nat Genet 2016)

  Whole-exome sequencing of 660 lung ADC and 484 lung SqCC tumor/normal pairs.

  Lung and pleuraTCGA (other releases)Source code nsclcPubMed 1

• Atypical Small Cell Lung Cancer (MSK, Cancer Discov 2024)

  Targeted sequencing of 31 atypical small cell lung cancers lacking RB1 and TP53 co-inactivation and their matched normals via MSK-IMPACT, including structural variant analysis via whole-genome sequencing. This data is…

  Lung and pleuraMSK studiesSource code lungPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.